[The change in bacterial flora and antibiotic resistance of bacteria of burn patients in our hospital during 1986-1996].
OBJECTIVE
In this article we investigated and analyzed the pathogenetic bacteria of burn infection and their drug resistance in recent 5 years from 1991.


METHODS
The patients are divided into 2 groups. The 1st group is from June 1986 to May 1991, and the 2nd group is from June 1991 to June 1996. Blood culture and burn wound bacteria culture were done, and bacteria and their drug sensitivity were analyzed.


RESULTS
In blood culture, Micrococcus had risen to rank the top (21.6%), while Staphylococcus aureus fell to rank the third. Among these G+ cocci comprised 56.5%, and G- bacilli 30.1%. In burn wound culture, Pseudomonas aeruginosa with rate of 18.1% was still in the 1st place. Enterobacter cloacae was in the 2nd place with the rate of 13.1%. Among these G- bacilli comprised 58.6%, G+ cocci 35.3%. Micrococcus enterobacter cloacae, Pseudomonas maltophilia, fecal Staphylococcus and candida albicans increased remarkably.


CONCLUSIONS
The changes of pathogenetic bacteria of burn infection and bacteria drug resistance have certain relations with the wide usage of broad spectrum antibiotics such as cefazidime and imipenem.
Xue
B
B
1st Clinical College, China Medical University, Shenyang 110001.
Liu
X
X
Tang
M
M
D000193:Actinomycetales Infections / Q000188:drug therapy / Q000453:epidemiology; D000293:Adolescent; D000328:Adult; D000368:Aged; D000668:Ampicillin Resistance; D002056:Burns / Q000382:microbiology*; D018550:Cephalosporin Resistance; D002648:Child; D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D008297:Male; D008837:Micrococcus / Q000187:drug effects / Q000302:isolation & purification*; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy / Q000453:epidemiology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification*